Skip to main content
    B

    Biovie Inc (BIVI)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $1.44
    -0.07 (-4.42%)

    Market Cap: $12.12M

    Last updated: Nov 17, 2026 at 11:02 AM ET

    Biovie Inc (BIVI) Financials: Revenue, Profit and Cash Flow

    Updated Nov 6, 2026. Financial statements from company filings, amounts in US dollars.

    Biovie reported revenue of $0 for the fiscal year ended Jun 30, 2026. That year, net income was -$22.07M and operating cash flow was -$19.02M. The quarter ended Sep 30, 2026 had revenue of $0 and net income of -$5.61M.

    Revenue and Margins

    The company reported no revenue in the fiscal year ended Jun 2026, with an operating loss of $22.65M.

    Fiscal yearRevenueGrowthGross marginOperating marginNet margin
    Jun 2026$0N/AN/AN/AN/A
    Jun 2025$0N/AN/AN/AN/A
    Jun 2024$0N/AN/AN/AN/A
    Jun 2023$0N/AN/AN/AN/A
    Jun 2022$0N/AN/AN/AN/A
    Jun 2021$0N/AN/AN/AN/A
    Jun 2020$0N/AN/AN/AN/A
    Jun 2019$0N/AN/AN/AN/A
    Jun 2018$0N/AN/AN/AN/A
    Jun 2017$0N/AN/AN/AN/A
    Annual, fiscal years ended Jun 2017 to Jun 2026

    Income Statement

    In the fiscal year ended Jun 2026, the net loss widened from the year before. In the quarter ended Sep 2026, the net loss widened from the same quarter a year earlier.

    Annual

    Line itemJun 2026Jun 2025Jun 2024Jun 2023Jun 2022Jun 2021Jun 2020Jun 2019Jun 2018Jun 2017
    Cost of revenue$0$0$0$0$0$0$0$0$0$285.39K
    Gross profit$0$0$0$0$0$0$0$0$0-$285.39K
    Research and development$13.96M$9.27M$23.10M$33.30M$17.26M$133.19M$1.15M$1.01M$370.85K$466.35K
    Operating income-$22.65M-$18.07M-$32.18M-$45.08M-$27.25M-$138.05M-$2.69M-$2.50M-$2.37M-$1.55M
    Net income-$22.07M-$17.54M-$32.12M-$50.26M-$26.08M-$130.25M-$16.68M-$2.44M-$2.41M-$1.33M
    EBITDA-$22.47M-$17.82M-$30.03MN/A-$23.64M-$129.54MN/A-$2.27M-$2.12M-$1.32M
    Fiscal years ended Jun 2017 to Jun 2026

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Gross profit$0N/A$0$0$0-$57.34K$0$0$0-$57.34K$0$0
    Operating income-$5.65M-$5.72M-$5.39M-$6.26M-$5.28M-$3.66M-$2.99M-$7.29M-$4.12M-$4.79M-$7.73M-$8.78M
    Net income-$5.61M-$5.65M-$5.27M-$6.07M-$5.09M-$3.49M-$2.79M-$7.11M-$4.15M-$4.94M-$8.07M-$8.40M
    Last 12 quarters

    Balance Sheet

    As of Jun 2026, cash and equivalents of $8.98M were 63.0% of total assets of $14.25M, against total liabilities of $3.98M.

    Annual

    Line itemJun 2026Jun 2025Jun 2024Jun 2023Jun 2022Jun 2021Jun 2020Jun 2019Jun 2018Jun 2017
    Total assets$14.25M$21.56M$25.21M$35.10M$20.11M$6.05M$2.08M$2.57M$2.18M$2.36M
    Current assets$13.64M$20.70M$24.05M$34.04M$18.78M$4.61M$412.98K$674.07K$45.80K$5.14K
    Cash and equivalents$8.98M$17.54M$23.84M$19.46M$18.64M$4.51M$37.20K$339.92K$45.80K$5.14K
    Total liabilities$3.98M$2.55M$9.70M$19.76M$16.44M$996.37K$23.58M$443.48K$2.06M$1.21M
    Short-term debtN/A$74.46K$5.70M$9.11M$0N/A$848.54K$0$0$35.00K
    Long-term debtN/AN/AN/A$5.23M$12.14M$0$62.50K$0$575.92K$575.92K
    Shareholder equity$10.27M$19.01M$15.51M$15.34M$3.67M$5.05M-$21.50M$2.13M$111.20K$1.16M
    Fiscal years ended Jun 2017 to Jun 2026

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Total assets$11.04M$14.25M$17.51M$22.50M$26.82M$21.56M$24.66M$25.69M$21.24M$25.21M$31.77M$21.49M
    Total liabilities$4.51M$3.98M$1.91M$3.24M$1.90M$2.55M$2.84M$1.77M$7.17M$9.70M$12.85M$14.00M
    Cash and equivalents$7.73M$8.98M$13.10M$20.54M$24.98M$17.54M$23.15M$24.41M$20.02M$23.84M$30.35M$20.23M
    Shareholder equity$6.53M$10.27M$15.61M$19.27M$24.92M$19.01M$21.82M$23.92M$14.07M$15.51M$18.93M$7.49M
    Last 12 quarters

    Cash Flow

    Operating cash flow was negative in the fiscal year ended Jun 2026.

    Annual

    Line itemJun 2026Jun 2025Jun 2024Jun 2023Jun 2022Jun 2021Jun 2020Jun 2019Jun 2018Jun 2017
    Operating cash flow-$19.02M-$19.03M-$27.95M-$40.25M-$18.99M-$10.45M-$1.63M-$2.50M-$621.34K-$623.62K
    Capital expendituresN/A$5$4$0$0$3$0$0$0$0
    Free cash flowN/A-$19.03M-$27.95M-$40.25M-$18.99M-$10.45M-$1.63M-$2.50M-$621.34K-$623.62K
    Dividends paidN/A$369.46B$886.42KN/AN/A$53.60M$17.10M$48.66K$0$0
    Investing cash flow$0$0$14.53M-$14.30M$0$0$0$0$0$0
    Financing cash flow$10.46M$12.73M$17.80M$55.37M$33.12M$14.93M$1.33M$2.80M$662.00K$505.00K
    Fiscal years ended Jun 2017 to Jun 2026

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Operating cash flow-$2.91M-$4.12M-$7.44M-$4.44M-$3.02M-$5.61M-$1.25M-$8.58M-$3.58M-$4.01M-$5.85M-$14.51M
    Capital expendituresN/AN/A$0$0$0$0$0$0$4$1$4$0
    Free cash flowN/AN/A-$7.44M-$4.44M-$3.02M-$5.61M-$1.25M-$8.58M-$3.58M-$4.01M-$5.85M-$14.51M
    Last 12 quarters

    Frequently Asked Questions About BIVI

    What is Biovie's annual revenue?

    Biovie reported revenue of $0 for the fiscal year ended Jun 30, 2026.

    Is Biovie profitable?

    No. Biovie reported net income of -$22.07M for the fiscal year ended Jun 30, 2026.

    How much debt does Biovie have?

    The balance sheet dated Jun 30, 2026 reported cash and equivalents of $8.98M.